Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences

Ji Young Oh, Jae Il Shin, Ji Young Oh, Jae Il Shin

Abstract

Hyponatremia (sodium levels of <135 mEq/L) is one of the most common electrolyte imbalances in clinical practice, especially in patients with neurologic diseases. Hyponatremia can cause cerebral edema and brain herniation; therefore, prompt diagnosis and proper treatment is important in preventing morbidity and mortality. Among various causes of hyponatremia, diagnosing syndrome of inappropriate antidiuretic hormone secretion (SIADH) and cerebral/renal salt wasting syndrome (C/RSW) is difficult due to many similarities. SIADH is caused by excess of renal water reabsorption through inappropriate antidiuretic hormone secretion, and fluid restriction is the treatment of choice. On the other hand, C/RSW is caused by natriuresis, which is followed by volume depletion and negative sodium balance and replacement of water and sodium is the mainstay of treatment. Determinating volume status in hyponatremic patients is the key point in differential between SIADH and C/RSW. However, in most situations, differential diagnosis of these two diseases is difficult because they overlap in many clinical and laboratory aspects, especially to assess differences in volume status of these patients. Although distinction between the SIADH and C/RSW is difficult, improvement of hypouricemia and an increased fractional excretion of uric acid after the correction of hyponatremia in SIADH, not in C/RSW, may be one of the helpful points in discriminating the two diseases. In this review, we compare these two diseases regarding the pathophysiologic mechanisms, diagnosis, and therapeutic point of view.

Keywords: cerebral/renal salt wasting syndrome; fractional excretion of urate; hyponatremia; syndrome of inappropriate antidiuretic hormone secretion; volume status.

References

    1. Bussmann C, Bast T, Rating D. Hyponatraemia in children with acute CNS disease: SIADH or cerebral salt wasting? Childs Nerv Syst (2001) 17(1–2):58–62.
    1. Moritz ML, Ayus JC. Management of hyponatremia in various clinical situations. Curr Treat Options Neurol (2014) 16(9):310.10.1007/s11940-014-0310-9
    1. Carandang F, Anglemyer A, Longhurst CA, Krishnan G, Alexander SR, Kahana M, et al. Association between maintenance fluid tonicity and hospital-acquired hyponatremia. J Pediatr (2013) 163(6):1646–51.10.1016/j.jpeds.2013.07.020
    1. Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am (2010) 21(2):339–52.10.1016/j.nec.2009.10.011
    1. Carpenter J, Weinstein S, Myseros J, Vezina G, Bell MJ. Inadvertent hyponatremia leading to acute cerebral edema and early evidence of herniation. Neurocrit Care (2007) 6(3):195–9.10.1007/s12028-007-0032-x
    1. Adrogue HJ, Madias NE. Diagnosis and treatment of hyponatremia. Am J Kidney Dis (2014) 126(10 Suppl 1):S1–4210.1053/j.ajkd.2014.06.001
    1. Agrawal V, Agarwal M, Joshi SR, Ghosh AK. Hyponatremia and hypernatremia: disorders of water balance. J Assoc Physicians India (2008) 56:956–64.
    1. Tzamaloukas AH, Malhotra D, Rosen BH, Raj DS, Murata GH, Shapiro JI. Principles of management of severe hyponatremia. J Am Heart Assoc (2013) 2(1):e005199.10.1161/jaha.112.005199
    1. Kamoi K, Toyama M, Ishibashi M, Yamaji T. Hyponatremia and osmoregulation of vasopressin secretion in patients with intracranial bleeding. J Clin Endocrinol Metab (1995) 80(10):2906–11.10.1210/jcem.80.10.7559873
    1. Adrogue HJ, Madias NE. The challenge of hyponatremia. J Am Soc Nephrol (2012) 23(7):1140–810.1681/asn.2012020128
    1. Frouget T. The syndrome of inappropriate antidiuresis. Rev Med Interne (2012) 33(10):556–6610.1016/j.revmed.2012.07.005
    1. Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med (1957) 23(4):529–4210.1016/0002-9343(57)90224-3
    1. Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab (2003) 14(4):182–7.10.1016/S1043-2760(03)00048-1
    1. Cogan MG. Atrial natriuretic peptide. Kidney Int (1990) 37(4):1148–6010.1038/ki.1990.98
    1. Peri A, Pirozzi N, Parenti G, Festuccia F, Mene P. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Endocrinol Invest (2010) 33(9):671–82.10.3275/7290
    1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med (1998) 339(5):321–810.1056/nejm199807303390507
    1. Peters JP, Welt LG, Sims EA, Orloff J, Needham J. A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians (1950) 63:57–64.
    1. Nelson PB, Seif SM, Maroon JC, Robinson AG. Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg (1981) 55(6):938–41.10.3171/jns.1981.55.6.0938
    1. Sorkhi H, Salehi Omran MR, Barari Savadkoohi R, Baghdadi F, Nakhjavani N, Bijani A. CSWS versus SIADH as the probable causes of hyponatremia in children with acute CNS disorders. Iran J Child Neurol (2013) 7(3):34–9.
    1. Jimenez R, Casado-Flores J, Nieto M, Garcia-Teresa MA. Cerebral salt wasting syndrome in children with acute central nervous system injury. Pediatr Neurol (2006) 35(4):261–3.10.1016/j.pediatrneurol.2006.05.004
    1. Hardesty DA, Kilbaugh TJ, Storm PB. Cerebral salt wasting syndrome in post-operative pediatric brain tumor patients. Neurocrit Care (2012) 17(3):382–7.10.1007/s12028-011-9618-4
    1. Maesaka JK, Miyawaki N, Palaia T, Fishbane S, Durham JH. Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int (2007) 71(8):822–610.1038/sj.ki.5002093
    1. Maesaka JK, Imbriano LJ, Ali NM, Ilamathi E. Is it cerebral or renal salt wasting? Kidney Int (2009) 76(9):934–8.10.1038/ki.2009.263
    1. Rabinstein AA, Wijdicks EF. Hyponatremia in critically ill neurological patients. Neurologist (2003) 9(6):290–30010.1097/01.nrl.0000095258.07720.89
    1. Kim DK, Joo KW. Hyponatremia in patients with neurologic disorders. Electrolyte Blood Press (2009) 7(2):51–7.10.5049/ebp.2009.7.2.51
    1. Steele MK, Gardner DG, Xie PL, Schultz HD. Interactions between ANP and ANG II in regulating blood pressure and sympathetic outflow. Am J Physiol (1991) 260(6 Pt 2):R1145–51.
    1. Schweda F, Friis U, Wagner C, Skott O, Kurtz A. Renin release. Physiology (2007) 22:310–9.10.1152/physiol.00024.2007
    1. Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature (1986) 324(6096):473–6.10.1038/324473a0
    1. Damaraju SC, Rajshekhar V, Chandy MJ. Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis. Neurosurgery (1997) 40(2):312–6.10.1097/00006123-199702000-00015
    1. Harrigan MR. Cerebral salt wasting syndrome. Crit Care Clin (2001) 17(1):125–38.10.1016/S0749-0704(05)70155-X
    1. Sherman RA, Eisinger RP. The use (and misuse) of urinary sodium and chloride measurements. JAMA (1982) 247(22):3121–410.1001/jama.247.22.3121
    1. Winter SD. Measurement of urine electrolytes: clinical significance and methods. Crit Rev Clin Lab Sci (1981) 14(3):163–87.10.3109/10408368109105863
    1. Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol (2008) 3(4):1175–8410.2215/cjn.04431007
    1. Carlotti AP, Bohn D, Rutka JT, Singh S, Berry WA, Sharman A, et al. A method to estimate urinary electrolyte excretion in patients at risk for developing cerebral salt wasting. J Neurosurg (2001) 95(3):420–4.10.3171/jns.2001.95.3.0420
    1. Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol (2008) 19(2):194–6.10.1681/asn.2007101118
    1. Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. 1957. J Am Soc Nephrol (2001) 12(12):2860–70.
    1. Maesaka JK, Fishbane S. Regulation of renal urate excretion: a critical review. Am J Kidney Dis (1998) 32(6):917–33.10.1016/S0272-6386(98)70067-8
    1. Fenske W, Stork S, Koschker AC, Blechschmidt A, Lorenz D, Wortmann S, et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab (2008) 93(8):2991–7.10.1210/jc.2008-0330
    1. Maesaka JK, Gupta S, Fishbane S. Cerebral salt-wasting syndrome: does it exist? Nephron (1999) 82(2):100–910.1159/000045384
    1. Kim JS, Lee JY, Park H, Han BG, Choi SO, Yang JW. Estimation of body fluid volume by bioimpedance spectroscopy in patients with hyponatremia. Yonsei Med J (2014) 55(2):482–6.10.3349/ymj.2014.55.2.482
    1. Fenech M, Maasrani M, Jaffrin MY. Fluid volumes determination by impedance spectroscopy and hematocrit monitoring: application to pediatric hemodialysis. Artif Organs (2001) 25(2):89–98.10.1046/j.1525-1594.2001.025002089.x
    1. McJunkin JE, de los Reyes EC, Irazuzta JE, Caceres MJ, Khan RR, Minnich LL, et al. La Crosse encephalitis in children. N Engl J Med (2001) 344(11):801–710.1056/nejm200103153441103
    1. Suarez JI. Treatment of acute brain edema. Rev Neurol (2001) 32(3):275–81.
    1. Moritz ML, Ayus JC. New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatr Nephrol (2010) 25(7):1225–38.10.1007/s00467-009-1323-6
    1. Boulard G, Marguinaud E, Sesay M. Osmotic cerebral oedema: the role of plasma osmolarity and blood brain barrier. Ann Fr Anesth Reanim (2003) 22(3):215–9.10.1016/S0750-7658(03)00009-1
    1. Olson JE, Banks M, Dimlich RV, Evers J. Blood-brain barrier water permeability and brain osmolyte content during edema development. Acad Emerg Med (1997) 4(7):662–73.10.1111/j.1553-2712.1997.tb03757.x
    1. King JD, Rosner MH. Osmotic demyelination syndrome. Am J Med Sci (2010) 339(6):561–7.10.1097/MAJ.0b013e3181d3cd78
    1. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med (2000) 342(21):1581–910.1056/nejm200005253422107
    1. Esposito P, Piotti G, Bianzina S, Malul Y, Dal Canton A. The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract (2011) 119(1):c62–73.10.1159/000324653
    1. Pillai BP, Unnikrishnan AG, Pavithran PV. Syndrome of inappropriate antidiuretic hormone secretion: revisiting a classical endocrine disorder. Indian J Endocrinol Metab (2011) 15(Suppl 3):S208–15.10.4103/2230-8210.84870
    1. Decaux G. SIADH and vaptans. Ann Endocrinol (2012) 73(2):130–410.1016/j.ando.2012.04.005
    1. Jones RC, Rajasekaran S, Rayburn M, Tobias JD, Kelsey RM, Wetzel GT, et al. Initial experience with conivaptan use in critically ill infants with cardiac disease. J Pediatr Pharmacol Ther (2012) 17(1):78–83.10.5863/1551-6776-17.1.78
    1. Horibata Y, Murakami T, Niwa K. Effect of the oral vasopressin receptor antagonist tolvaptan on congestive cardiac failure in a child with restrictive cardiomyopathy. Cardiol Young (2014) 24(1):155–7.10.1017/s1047951112002272
    1. Konstam MA, Gheorghiade M, Burnett JC, Jr., Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA (2007) 297(12):1319–31.10.1001/jama.297.12.1319
    1. Malhotra I, Gopinath S, Janga KC, Greenberg S, Sharma SK, Tarkovsky R. Unpredictable nature of tolvaptan in treatment of hypervolemic hyponatremia: case review on role of vaptans. Case Rep Endocrinol (2014) 2014:807054.10.1155/2014/807054
    1. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2012) 367(25):2407–18.10.1056/NEJMoa1205511
    1. Robertson GL. Vaptans for the treatment of hyponatremia. Nat Rev Endocrinol (2011) 7(3):151–6110.1038/nrendo.2010.229
    1. Aditya S, Rattan A. Vaptans: A new option in the management of hyponatremia. Int J Appl Basic Med Res (2012) 2(2):77–83.10.4103/2229-516x.106347
    1. Yamaki T, Tano-oka A, Takahashi A, Imaizumi T, Suetake K, Hashi K. Cerebral salt wasting syndrome distinct from the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Acta Neurochir (1992) 115(3–4):156–62.10.1007/BF01406376
    1. Moritz ML. Syndrome of inappropriate antidiuresis and cerebral salt wasting syndrome: are they different and does it matter? Pediatr Nephrol (2012) 27(5):689–93.10.1007/s00467-012-2112-1
    1. Wijdicks EF, Vermeulen M, van Brummelen P, van Gijn J. The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg (1988) 90(3):209–14.10.1016/0303-8467(88)90023-6
    1. Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg (1999) 91(6):947–52.10.3171/jns.1999.91.6.0947
    1. Kinik ST, Kandemir N, Baykan A, Akalan N, Yordam N. Fludrocortisone treatment in a child with severe cerebral salt wasting. Pediatr Neurosurg (2001) 35(4):216–9.10.1159/000050424
    1. Choi MJ, Oh YS, Park SJ, Kim JH, Shin JI. Cerebral salt wasting treated with fludrocortisone in a 17-year-old boy. Yonsei Med J (2012) 53(4):859–62.10.3349/ymj.2012.53.4.859

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する